Study of ALXN2050 in Proliferative Lupus Nephritis (LN) and Immunoglobulin A Nephropathy (IgAN) - NCT05097989

Both Cohorts: Percentage Change In Proteinuria From Baseline To Week 26, Both Cohorts: Percentage Change In Proteinuria From Baseline To Week 50, Both Cohorts: Participants Achieving > 30% And > 50% Reduction In Proteinuria At Week 26 And Week 50 Compared To Baseline, (and 13 more...)